1. Home
  2. CYD vs CRVS Comparison

CYD vs CRVS Comparison

Compare CYD & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$23.45

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$10.52

Market Cap

811.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
CRVS
Founded
1951
2014
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
811.8M
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
CYD
CRVS
Price
$23.45
$10.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $56.70
$33.14
AVG Volume (30 Days)
212.1K
★ 1.0M
Earning Date
08-07-2026
11-03-2026
Dividend Yield
★ 3.64%
N/A
EPS Growth
N/A
★ 48.04
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
$32.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.53
$6.39
52 Week High
$61.48
$26.95

Technical Indicators

Market Signals
Indicator
CYD
CRVS
Relative Strength Index (RSI) 22.01 44.65
Support Level N/A $9.21
Resistance Level $35.66 $13.73
Average True Range (ATR) 1.48 0.60
MACD -0.20 0.16
Stochastic Oscillator 3.23 73.14

Price Performance

Historical Comparison
CYD
CRVS

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: